Ignite Creation Date:
2024-05-06 @ 4:30 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05007236
Status:
COMPLETED
Last Update Posted:
2022-04-21
First Post:
2021-08-09
Brief Title:
Study to Evaluate the Efficacy and Safety of Oral RP7214 a DHODH Inhibitor in Patients With Symptomatic Mild COVID-19 Infection
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Rhizen Pharmaceuticals SA
Organization Data
Organization:
Rhizen Pharmaceuticals SA
Class:
INDUSTRY
Study ID:
RP7214-2101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rhizen Pharmaceuticals SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Incozen Therapeutics Pvt Ltd | UNKNOWN |